Stockreport

Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases

OPHTHOTECH CORP COMMON  (OPHT) 
Last ophthotech corp common earnings: 2/26 07:15 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ophthotech.com/investor-relations
PDF NEW YORK--(BUSINESS WIRE)-- Ophthotech Corporation (NASDAQ: OPHT) announced today that the Company has converted its option and entered into an exclus [Read more]